Free Trial

MDxHealth (MDXH) Stock Price, News & Analysis

MDxHealth logo
$2.43 +0.04 (+1.67%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$2.38 -0.06 (-2.26%)
As of 08/1/2025 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About MDxHealth Stock (NASDAQ:MDXH)

Key Stats

Today's Range
$2.34
$2.43
50-Day Range
$1.97
$2.57
52-Week Range
$1.35
$3.50
Volume
192,290 shs
Average Volume
60,566 shs
Market Capitalization
$114.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Buy

Company Overview

MDxHealth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

MDXH MarketRank™: 

MDxHealth scored higher than 57% of companies evaluated by MarketBeat, and ranked 424th out of 919 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MDxHealth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MDxHealth has only been the subject of 1 research reports in the past 90 days.

  • Read more about MDxHealth's stock forecast and price target.
  • Earnings Growth

    Earnings for MDxHealth are expected to grow in the coming year, from ($1.15) to ($0.61) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MDxHealth is -2.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MDxHealth is -2.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MDxHealth has a P/B Ratio of 7.84. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about MDxHealth's valuation and earnings.
  • Percentage of Shares Shorted

    0.20% of the float of MDxHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    MDxHealth has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MDxHealth has recently decreased by 19.73%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    MDxHealth does not currently pay a dividend.

  • Dividend Growth

    MDxHealth does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.20% of the float of MDxHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    MDxHealth has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MDxHealth has recently decreased by 19.73%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    MDxHealth has a news sentiment score of 1.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for MDxHealth this week, compared to 1 article on an average week.
Receive MDXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter.

MDXH Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
MDxHealth CFO Kalfus Resigns
MDxHealth Reports Q1-2025 Results
See More Headlines

MDXH Stock Analysis - Frequently Asked Questions

MDxHealth's stock was trading at $2.37 at the beginning of the year. Since then, MDXH stock has increased by 2.5% and is now trading at $2.43.

MDxHealth SA (NASDAQ:MDXH) issued its quarterly earnings results on Wednesday, May, 14th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.13) by $0.06. The firm earned $24.29 million during the quarter, compared to the consensus estimate of $22.62 million. MDxHealth had a negative net margin of 41.02% and a negative trailing twelve-month return on equity of 492.11%.
Read the conference call transcript
.

Shares of MDxHealth reverse split before market open on Friday, December 29th 2023.The 1-10 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

MDxHealth (MDXH) raised $45 million in an initial public offering (IPO) on Thursday, November 4th 2021. The company issued 3,750,000 shares at $12.00 per share.

Top institutional investors of MDxHealth include Delta Investment Management LLC (0.37%).
View institutional ownership trends
.

Shares of MDXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MDxHealth investors own include Cognition Therapeutics (CGTX), LAVA Therapeutics (LVTX), Coeptis Therapeutics (COEP), PHX Minerals (PHX), PayPal (PYPL), Arcadia Biosciences (RKDA) and Alimera Sciences (ALIM).

Company Calendar

Last Earnings
5/14/2025
Today
8/02/2025
Next Earnings (Estimated)
8/20/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
N/A
Current Symbol
NASDAQ:MDXH
CIK
1872529
Employees
300
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$6.00
Potential Upside/Downside
+188.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$38.07 million
Net Margins
-41.02%
Pretax Margin
-40.47%
Return on Equity
-492.11%
Return on Assets
-23.00%

Debt

Debt-to-Equity Ratio
13.81
Current Ratio
2.00
Quick Ratio
1.92

Sales & Book Value

Annual Sales
$90.05 million
Price / Sales
1.28
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.31 per share
Price / Book
7.84

Miscellaneous

Outstanding Shares
47,290,000
Free Float
46,484,000
Market Cap
$114.91 million
Optionable
Not Optionable
Beta
1.41

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:MDXH) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners